The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...
From loss of skin elasticity to hair density, supplements that offer targeted support for GLP-1 users, as well as those that ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
A study found that disruptions in homeostasis from quick weight reduction by consuming GLP-1 drug can elevate cortisol - a ...
This is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.
For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with reductions in risk-adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback